CSIMarket
 


Vericel Corporation  (VCEL)
Other Ticker:  
 


Vericel's Pre-Tax Profit Margin by quarter

Trends, Rankings, Statistics



VCEL Pre-Tax Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 23.35 % 18.24 % 23.96 % 13.7 % 10.72 %
Seq. Revenue Change 42.59 % -0.74 % 11.96 % -22.16 % 36.69 %
Revenue In Millions $65.00 $45.58 $45.92 $41.02 $52.69
Pre-Tax Profit Margin 21.68 % -8.66 % -10.93 % -18.27 % 12.57 %
Pre-Tax Profit Margin Total Ranking # 608 # # # # 1623
Pre-Tax Income In Millions $14.09 $-3.95 $-5.02 $-7.50 $6.62
Y / Y Pre-Tax Income Change 112.82 % - - - 57.33 %
Seq. Pre-Tax Income Change - - - - -


Commenting fourth Quarter 2023 Pre-Tax Profit Margin
Vericel Corporation achieved Pre-Tax Income of $14 millions compare to Pre-Tax Loss of $-3.95 millions recorded in previous quarter. Revenue increased by 42.59 % Company accomplished above average Pre-Tax Profit Margin with 21.68 %.

Observing fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 10 other companies have achieved higher Pre-Tax Profit Margin. While Pre-Tax Profit Margin overall ranking has deteriorated compare to previous quarter from to 608.

VCEL's Pre-Tax Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 11
Healthcare Sector # 54
Overall # 607

Pre-Tax Profit Margin Statistics
High Average Low
27.42 % 15.02 % 1.23 %
(Dec 31 2020)   (Dec 31 2017)




Other Pre-Tax Profit Margin Profitability Ratios
VCEL's Cumulative Pre-Tax Profit Margin
Biotechnology & Pharmaceuticals Industry Pre-Tax Profit Margin Trends and Statistics
Healthcare Sector Pre-Tax Profit Margin Statistics
Pre-Tax Profit Margin Profitability Trends for overall market
VCEL's Pre-Tax Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Pre-Tax Profit Margin
Lowest Ranking Pre-Tax Profit Margin
Pre-Tax Profit Margin Profit Margin for VCEL's Competitors
Pre-Tax Profit Margin Profit Margin for Vericel's Suppliers
Pre-Tax Profit Margin Profit Margin for VCEL's Customers

You may also want to know
VCEL's Annual Growth Rates VCEL's Profitability Ratios VCEL's Asset Turnover Ratio VCEL's Dividend Growth
VCEL's Roe VCEL's Valuation Ratios VCEL's Financial Strength Ratios VCEL's Pre-Tax Income Growth
VCEL's Roa VCEL's Inventory Turnover Ratio VCEL's Growth Rates VCEL's Dividend Comparisons


Companies with similar Pre-Tax Profit Margin in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Pre-Tax Profit MarginDec 31 2023 MRQ Pre-Tax IncomeDec 31 2023 MRQ Revenue
Halozyme Therapeutics Inc   43.98 %$ 101.175 $ 230.039 
Exelixis Inc   42.96 %$ 206.078 $ 479.652 
Neurocrine Biosciences Inc   38.47 %$ 198.200 $ 515.200 
Biontech Se  31.06 %$ 1,328.432 $ 4,277.280 
Krystal Biotech Inc   25.29 %$ 10.657 $ 42.143 
Gilead Sciences Inc   23.24 %$ 1,653.000 $ 7,114.000 
Qiagen N v   22.61 %$ 429.809 $ 1,900.688 
Vericel Corporation  21.68 %$ 14.093 $ 64.996 
Bio techne Corp  12.25 %$ 33.387 $ 272.587 
Biogen Inc   12.22 %$ 291.600 $ 2,386.300 
Amgen Inc   10.40 %$ 852.000 $ 8,196.000 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com